CGEN
Price
$1.76
Change
+$0.02 (+1.15%)
Updated
Jul 3 closing price
Capitalization
165.65M
24 days until earnings call
OCS
Price
$18.66
Change
-$0.34 (-1.79%)
Updated
Jul 7, 11:35 AM (EDT)
Capitalization
969.64M
Interact to see
Advertisement

CGEN vs OCS

Header iconCGEN vs OCS Comparison
Open Charts CGEN vs OCSBanner chart's image
Compugen
Price$1.76
Change+$0.02 (+1.15%)
Volume$94.6K
Capitalization165.65M
Oculis Holding AG
Price$18.66
Change-$0.34 (-1.79%)
Volume$350
Capitalization969.64M
CGEN vs OCS Comparison Chart in %
Loading...
CGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGEN vs. OCS commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEN is a Hold and OCS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (CGEN: $1.76 vs. OCS: $19.00)
Brand notoriety: CGEN and OCS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEN: 42% vs. OCS: 30%
Market capitalization -- CGEN: $165.65M vs. OCS: $969.64M
CGEN [@Biotechnology] is valued at $165.65M. OCS’s [@Biotechnology] market capitalization is $969.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEN’s FA Score shows that 1 FA rating(s) are green whileOCS’s FA Score has 0 green FA rating(s).

  • CGEN’s FA Score: 1 green, 4 red.
  • OCS’s FA Score: 0 green, 5 red.
According to our system of comparison, CGEN is a better buy in the long-term than OCS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEN’s TA Score shows that 4 TA indicator(s) are bullish while OCS’s TA Score has 3 bullish TA indicator(s).

  • CGEN’s TA Score: 4 bullish, 4 bearish.
  • OCS’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, OCS is a better buy in the short-term than CGEN.

Price Growth

CGEN (@Biotechnology) experienced а +7.98% price change this week, while OCS (@Biotechnology) price change was -2.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.59%. For the same industry, the average monthly price growth was +13.92%, and the average quarterly price growth was -0.53%.

Reported Earning Dates

CGEN is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+5.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCS($970M) has a higher market cap than CGEN($166M). OCS (63.06) and CGEN (60.33) have similar P/E ratio . CGEN YTD gains are higher at: 15.033 vs. OCS (11.765). CGEN has higher annual earnings (EBITDA): -14.79M vs. OCS (-101.78M). OCS has more cash in the bank: 182M vs. CGEN (104M). OCS has less debt than CGEN: OCS (1.1M) vs CGEN (2.77M). CGEN has higher revenues than OCS: CGEN (27.6M) vs OCS (0).
CGENOCSCGEN / OCS
Capitalization166M970M17%
EBITDA-14.79M-101.78M15%
Gain YTD15.03311.765128%
P/E Ratio60.3363.0696%
Revenue27.6M0-
Total Cash104M182M57%
Total Debt2.77M1.1M251%
FUNDAMENTALS RATINGS
CGEN: Fundamental Ratings
CGEN
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
31
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGENOCS
RSI
ODDS (%)
Bearish Trend 5 days ago
89%
N/A
Stochastic
ODDS (%)
Bearish Trend 5 days ago
85%
Bullish Trend 5 days ago
50%
Momentum
ODDS (%)
Bullish Trend 5 days ago
86%
Bearish Trend 5 days ago
34%
MACD
ODDS (%)
Bullish Trend 5 days ago
78%
Bearish Trend 5 days ago
42%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
81%
Bearish Trend 5 days ago
48%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
79%
Bearish Trend 5 days ago
48%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 21 days ago
72%
Declines
ODDS (%)
Bearish Trend 12 days ago
89%
Bearish Trend 18 days ago
63%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
88%
N/A
Aroon
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 5 days ago
57%
View a ticker or compare two or three
Interact to see
Advertisement
CGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SEOVF0.11N/A
+1.72%
SERNOVA BIOTHERAPEUTICS INC.
MSADF23.00N/A
N/A
MS&AD Insurance Group Holdings, Inc.
SOLTF6.60N/A
N/A
Nxera Pharma Co.,Ltd.
NRGYF0.07N/A
N/A
New Energy Metals Corp.
SSSAF39.85-3.65
-8.39%
SHURGARD SELF STORAGE LTD.

CGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEN has been loosely correlated with BDTX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEN jumps, then BDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEN
1D Price
Change %
CGEN100%
+1.15%
BDTX - CGEN
46%
Loosely correlated
-0.77%
ROIV - CGEN
41%
Loosely correlated
+0.18%
ARWR - CGEN
40%
Loosely correlated
-0.65%
RLAY - CGEN
40%
Loosely correlated
+0.83%
BBIO - CGEN
40%
Loosely correlated
+2.71%
More

OCS and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCS has been loosely correlated with HURA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if OCS jumps, then HURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCS
1D Price
Change %
OCS100%
-0.81%
HURA - OCS
35%
Loosely correlated
+0.40%
SNSE - OCS
34%
Loosely correlated
-2.54%
CUE - OCS
33%
Loosely correlated
+0.46%
BIORQ - OCS
31%
Poorly correlated
-6.25%
CGEN - OCS
29%
Poorly correlated
+1.15%
More